Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

When Is On-Label Speech Off-Label Promotion? Par Links The Two In Suit Against FDA

Oct 24 2011

• By Brenda Sandburg

Related Content

Botox Reimbursement Training Is Driving Factor In Allergan Settlement With DOJ

Sep 01 2010

Lilly $1.4B Zyprexa Settlement Is Biggest Ever, But Some State Claims Still Pending

Jan 15 2009

FDA Off-Label Regs Face Cave-In Risk After Supreme Court Data-Mining Ruling

Jul 04 2011

Par Sues FDA To Get "Tailored" Rules On Off-Label Promotion

Oct 17 2011

Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case

Oct 24 2005

Sales Rep's Free Speech Challenge Of Off-Label Regs Boosted By Sorrell Ruling

Sep 05 2011

Paving New Regs: Firms Petition For Smoother Ride For Off-Label Communications

Jul 11 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window